These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 110445)

  • 1. Experimental animal models of adriamycin cardiotoxicity.
    Doroshow JH; Locker GY; Myers CE
    Cancer Treat Rep; 1979 May; 63(5):855-60. PubMed ID: 110445
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An in vivo animal model to study chronic adriamycin cardiotoxicity: a P-31 nuclear magnetic resonance spectroscopy investigation.
    Thompson RT; Marsh GD; Butland T; Sprague C; Sanford SE; Peemoeller H; Driedger AA; Inch WR
    In Vivo; 1991; 5(1):13-6. PubMed ID: 1932618
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Abrogation of adriamycin-induced cardiotoxicity by selenium in rabbits.
    Dimitrov NV; Hay MB; Siew S; Hudler DA; Charamella LJ; Ullrey DE
    Am J Pathol; 1987 Feb; 126(2):376-83. PubMed ID: 3826299
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Failure of the antioxidant vitamin E to protect against adriamycin-induced cardiotoxicity in the rabbit.
    Breed JG; Zimmerman AN; Dormans JA; Pinedo HM
    Cancer Res; 1980 Jun; 40(6):2033-8. PubMed ID: 7371038
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiac disease induced by chronic adriamycin administration in dogs and an evaluation of vitamin E and selenium as cardioprotectants.
    Van Vleet JF; Ferrans VJ; Weirich WE
    Am J Pathol; 1980 Apr; 99(1):13-42. PubMed ID: 7361854
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of vitamin E and selenium protection against chronic adriamycin toxicity in rabbits.
    Van Vleet JF; Ferrans VJ
    Cancer Treat Rep; 1980; 64(2-3):315-7. PubMed ID: 7407765
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adriamycin cardiotoxicity amelioration by alpha-tocopherol.
    Krivit W
    Am J Pediatr Hematol Oncol; 1979; 1(2):151-3. PubMed ID: 543510
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modulation by selenium supplementation of lipid peroxidation induced by chronic administration of adriamycin in rats.
    Coudray C; Hida H; Boucher F; De Leiris J; Favier A
    Nutrition; 1995; 11(5 Suppl):512-6. PubMed ID: 8748211
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preclinical animal models of cardiac protection from anthracycline-induced cardiotoxicity.
    Herman EH; Ferrans VJ
    Semin Oncol; 1998 Aug; 25(4 Suppl 10):15-21. PubMed ID: 9768819
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of alpha-tocopherol on the cardiotoxicity of adriamycin in the rat.
    Sonneveld P
    Cancer Treat Rep; 1978 Jul; 62(7):1033-6. PubMed ID: 278640
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of vitamin A administration on resistance of rat heart against doxorubicin-induced cardiotoxicity and lethality.
    Tesoriere L; Ciaccio M; Valenza M; Bongiorno A; Maresi E; Albiero R; Livrea MA
    J Pharmacol Exp Ther; 1994 Apr; 269(1):430-6. PubMed ID: 8169849
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Myocardial disease caused by adriamycin. Experimental animal models and possible pharmacologic prevention].
    Decorti G; Bartoli Klugmann F; Klugmann S
    Minerva Med; 1982 May; 73(19):1275-82. PubMed ID: 7078806
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adriamycin-induced cardiomyopathy. A rat model.
    Czarnecki A; Hinek A; Sołtysiak-Pawluczuk D
    Pol J Pharmacol Pharm; 1986; 38(2):171-7. PubMed ID: 3748888
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human carbonyl reductase overexpression in the heart advances the development of doxorubicin-induced cardiotoxicity in transgenic mice.
    Forrest GL; Gonzalez B; Tseng W; Li X; Mann J
    Cancer Res; 2000 Sep; 60(18):5158-64. PubMed ID: 11016643
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The synergistic effects of vitamin E and selenium in iron-overloaded mouse hearts.
    Bartfay WJ; Hou D; Brittenham GM; Bartfay E; Sole MJ; Lehotay D; Liu PP
    Can J Cardiol; 1998 Jul; 14(7):937-41. PubMed ID: 9706279
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adriamycin-induced myocardial toxicity: new solutions for an old problem?
    Outomuro D; Grana DR; Azzato F; Milei J
    Int J Cardiol; 2007 Apr; 117(1):6-15. PubMed ID: 16863672
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Peculiarities of adriamycin cardiotoxicity in spontaneously hypertensive rats (SHR).
    Herrmann HJ; Massow S; Moritz V; Norden C; Kühne C
    Biomed Biochim Acta; 1987; 46(8-9):S593-6. PubMed ID: 3435516
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential expression of HSP70 and ultrastructure of heart and liver tissues of rats treated with adriamycin: protective role of L-carnitine.
    Strauss M; Porras N
    Invest Clin; 2007 Mar; 48(1):33-43. PubMed ID: 17432542
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantitative experimental evaluation of adriamycin cardiotoxicity in the mouse.
    Bertazzoli C; Bellini O; Magrini U; Tosana MG
    Cancer Treat Rep; 1979; 63(11-12):1877-83. PubMed ID: 526920
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protective effect of Gingko biloba extract against doxorubicin-induced cardiotoxicity in mice.
    Naidu MU; Kumar KV; Mohan IK; Sundaram C; Singh S
    Indian J Exp Biol; 2002 Aug; 40(8):894-900. PubMed ID: 12597018
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.